International Flavors & Fragrances is working with an adviser to explore a potential sale of its pharma solutions business, Bloomberg News reported on Monday, citing people familiar with the matter.
The unit could fetch about $3.5 billion in sale, according to the report.
The pharma business was expected to garner interest from IFF’s peers and private equity firms, Bloomberg reported.
IFF’s pharma unit accounted for about 8% of the company’s total sales last year.
IFF did not immediately respond to a Reuters request for comment.
Source: Reuters.com